Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer (Q78245367)
Jump to navigation
Jump to search
scientific article published on 01 August 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer |
scientific article published on 01 August 1999 |
Statements
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer (English)
J Baselga
D Tripathy
J Mendelsohn
S Baughman
C C Benz
L Dantis
N T Sklarin
A D Seidman
C A Hudis
J Moore
P P Rosen
T Twaddell
I C Henderson
1 August 1999